Renal antioxidant enzymes and glutathione redox status in leptin-induced hypertension

Molecular and Cellular Biochemistry

Volumn 319, Issue 1-2, 2008, Pages 163-174

  Bełtowski, Jerzy ^a   Jamroz Wiśniewska, Anna ^a   Wójcicka, Grazyna ^a   Łowicka, Ewelina ^a   Wojtak, Andrzej ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b District Specialist Hospital   (Poland)

Author keywords

Extracellular signal regulated kinases; Glutathione; Na+,K+ ATPase; Nitric oxide; Obesity; Reactive oxygen species

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIOXIDANT; APOCYNIN; BUTHIONINE SULFOXIMINE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM ION; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERTENSION; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; RAT; SODIUM EXCRETION; TREATMENT DURATION; UPREGULATION;

ANIMALS; ANTIOXIDANTS; ENZYME INHIBITORS; HYDROGEN PEROXIDE; HYPERTENSION; KIDNEY; LEPTIN; MALE; OXIDATION-REDUCTION; RATS; RATS, WISTAR; SODIUM; SUPEROXIDES; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 55649108195     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9889-z     Document Type: Article

References (47)

1. Considine RV, Sinha MK, Heiman ML et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295. doi: 10.1056/NEJM199602013340503
2. Agata J, Masuda A, Takada M et al (1997) High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 10:1171-1174. doi: 10.1016/S0895-7061(97)00310-5
3. Shek EW, Brands MW, Hall JE (1998) Chronic leptin infusion increases arterial pressure. Hypertension 31:409-414
4. Aizawa-Abe M, Ogawa Y, Masuzaki H et al (2000) Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 105:1243-1252. doi: 10.1172/JCI8341
5. Mark AL, Schaffer RA, Correia MLG et al (1999) Contrasting blood pressure effects of obesity in leptin deficient ob/ob mice and agouti yellow obese mice. J Hypertens 17:1949-1953. doi: 10.1097/ 00004872-199917121-00026
6. Burgueño AL, Landa MS, Schuman ML et al (2007) Association between diencephalic thyroliberin and arterial blood pressure in agouti-yellow and ob/ob mice may be mediated by leptin. Metabolism 56:1439-1443. doi: 10.1016/j.metabol.2007.06.008
7. Mathew B, Patel SB, Reams GP et al (2007) Obesity-hypertension: Emerging concepts in pathophysiology and treatment. Am J Med Sci 334:23-30. doi: 10.1097/MAJ.0b013e3180959e4e
8. +-ATPase by leptin, nitric oxide, reactive oxygen species, and cyclic nucleotides: implications for obesity-associated hypertension. Clin Exp Hypertens 29:189-207. doi: 10.1080/10641960701361585
9. Ceriello A (2008) Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 31(Suppl 2):S181-S184. doi: 10.2337/ dc08-s245
10. Wilcox CS (2005) Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289:R913-R935. doi: 10.1152/ajpregu.00250.2005
11. Majid DS, Kopkan L (2007) Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. Clin Exp Pharmacol Physiol 34:946-952. doi: 10.1111/ j.1440-1681.2007.04642.x
12. Lee MY, Griendling KK (2008) Redox signaling, vascular function, and hypertension. Antioxid Redox Signal 10:1045-1060. doi: 10.1089/ ars.2007.1986
13. Ardanaz N, Pagano PJ (2006) Hydrogen peroxide as a paracrine vascular mediator: Regulation and signaling leading to dysfunction. Exp Biol Med 231:237-251
14. 2-induced PKB and ERK1/2 signaling. Cell Biochem Biophys 47:1-10. doi: 10.1159/000098118
15. Thakali K, Davenport L, Fink GD, Watts SW (2007) Cyclooxygenase, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase MAPK, Rho kinase, and Src mediate hydrogen peroxide-induced contraction of rat thoracic aorta and vena cava. J Pharmacol Exp Ther 320:236-243. doi: 10.1124/jpet.106.110650
16. 2 on salt-induced hypertension and renal injury. Am J Physiol Regul Integr Comp Physiol 289:R1573-R1579. doi: 10.1152/ajpregu.00525.2005
17. +-ATPase in the rat. Clin Exp Pharmacol Physiol 33:1216-1224. doi: 10.1111/j.1440-1681.2006.04513.x
18. Wójcicka G, Jamroz-Wiśniewska A, Widomska S et al (2008) Role of extracellular signal-regulated kinases (ERK) in leptin-induced hypertension. Life Sci 82:402-412. doi: 10.1016/j.lfs.2007.11.029
19. Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30:1191-1212. doi: 10.1016/S0891-5849(01)00480-4
20. Muthalif MM, Benter IF, Khandekar Z et al (2000) Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension. Hypertension 35:457-463
21. Hurst RO (1964) The determination of nucleotide phosphorus with a stannous chloride-hydrazine sulphate reagent. Can J Biochem Physiol 42:287-292
22. Moshage H, Kok B, Huizenga JR, Jansen PL (1995) Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem 41:892-896
23. Bełtowski J, Wójcicka G, Marciniak A, Jamroz A (2004) Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci 74:2987-3000. doi: 10.1016/ j.lfs.2003.10.029
24. Yuen JW, Benzie IF (2003) Hydrogen peroxide in urine as a potential biomarker of whole body oxidative stress. Free Radic Res 37:1209-1213. doi: 10.1080/10715760310001616032
25. Seelig GF, Meister A (1984) Gamma-glutamylcysteine synthetase interactions of an essential sulfhydryl group. J Biol Chem 259:3534-3538
26. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem 27:502-522. doi: 10.1016/ 0003-2697(69)90064-5
27. Lowry OH, Rosenbrough NI, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
28. Pham I, Sediame S, Maistre G et al (1997) Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Am J Physiol 273:R1457-R1464
29. Wild AC, Mulcahy RT (2000) Regulation of gamma-glutamylcysteine synthetase subunit gene expression: Insights into transcriptional control of antioxidant defenses. Free Radic Res 32:281-301. doi: 10.1080/ 10715760000300291
30. Soltaninassab SR, Sekhar KR, Meredith MJ, Freeman ML (2000) Multi-faceted regulation of gamma-glutamylcysteine synthetase. J Cell Physiol 182:163-170. doi 10.1002/ (SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1
31. Vaziri ND, Wang XQ, Oveisi F, Rad B (2000) Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36:142-146
32. 1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 51:367-375. doi: 10.1161/HYPERTENSIONAHA.107.102111
33. Cabassi A, Dumont EC, Girouard H et al (2001) Effects of chronic N -acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens 19:1233-1244. doi: 10.1097/00004872-200107000-00008
34. Pechánová O, Zicha J, Kojsová S et al (2006) Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clin Sci 110:235-242. doi: 10.1042/CS20050227
35. Zhang L, Fujii S, Igarashi J, Kosaka H (2004) Effects of thiol antioxidant on reduced nicotinamide adenine dinucleotide phosphate oxidase in hypertensive Dahl salt-sensitive rats. Free Radic Biol Med 37:1813-1820. doi: 10.1016/j.freeradbiomed.2004.08.019
36. Tian N, Rose RA, Jordan S et al (2006) N -acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. J Hypertens 24:2263-2270. doi: 10.1097/ 01.hjh.0000249705.42230.73
37. Sun Y, Zhang J, Lu L et al (2002) Aldosterone-induced inflammation in the rat heart: Role of oxidative stress. Am J Pathol 161:1773-1781
38. Rauchová H, Pechánová O, Kunes J et al (2005) Chronic N -acetylcysteine administration prevents development of hypertension in Nω-nitro-L-arginine methyl ester-treated rats: The role of reactive oxygen species. Hypertens Res 28:475-482. doi: 10.1291/ hypres.28.475
39. Song D, Hutchings S, Pang CC (2005) Chronic N -acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats. Eur J Pharmacol 508:205-210. doi: 10.1016/j.ejphar.2004.12.018
40. Olsson B, Johansson M, Gabrielsson J, Bolme P (1988) Pharmacokinetics and bioavailability of reduced and oxidized N -acetylcysteine. Eur J Clin Pharmacol 34:77-82. doi: 10.1007/BF01061422
41. Mondo CK, Zhang Y, de Macedo Possamai V et al (2006) N -acetylcysteine antagonizes the development but does not reverse ACTH-induced hypertension in the rat. Clin Exp Hypertens 28:73-84. doi: 10.1080/ 10641960500468219
42. Bourraindeloup M, Adamy C, Candiani G et al (2004) N -acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Circulation 110:2003-2009. doi: 10.1161/01.CIR.0000143630.14515.7C
43. Barford D (2004) The role of cysteine residues as redox-sensitive regulatory switches. Curr Opin Struct Biol 14:679-686. doi: 10.1016/ j.sbi.2004.09.012
44. Ying J, Clavreul N, Sethuraman M et al (2007) Thiol oxidation in signaling and response to stress: Detection and quantification of physiological and pathophysiological thiol modifications. Free Radic Biol Med 43:1099-11108. doi: 10.1016/j.freeradbiomed.2007.07.014
45. Zhang Y, Hogg N (2005) S-nitrosothiols: Cellular formation and transport. Free Radic Biol Med 38:831-838. doi: 10.1016/ j.freeradbiomed.2004.12.016
46. Yamauchi A, Ueda N, Hanafusa S et al (2002) Tissue distribution of and species differences in deacetylation of N-acetyl-L-cysteine and immunohistochemical localization of acylase I in the primate kidney. J Pharm Pharmacol 54:205-212. doi: 10.1211/0022357021778394
47. Arfsten D, Johnson E, Thitoff A et al (2004) Impact of 30-day oral dosing with N-acetyl-L-cysteine on Sprague-Dawley rat physiology. Int J Toxicol 23:239-247. doi: 10.1080/10915810490502041